You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 10,918,617


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,918,617 protect, and when does it expire?

Patent 10,918,617 protects BAFIERTAM and is included in one NDA.

This patent has nineteen patent family members in seven countries.

Summary for Patent: 10,918,617
Title:Fumarate ester pharmaceutical compositions
Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.
Inventor(s): Dyakonov; Tatyana (Greensboro, NC), Agnihotri; Sunil (Scarborough, ME), Fatmi; Aqeel A. (High Point, NC)
Assignee: BANNER LIFE SCIENCES LLC (High Point, NC)
Application Number:16/129,908
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,918,617: A Detailed Analysis

Introduction

Patent 10,918,617, like any other patent, is a complex document that outlines the invention, its scope, and the claims that define its boundaries. To analyze this patent, we need to delve into several key aspects, including the patent's subject matter, the claims made, and the broader patent landscape in the United States.

Patent Subject Matter

Overview of the Invention

To begin with, it is crucial to understand what the patent is about. Patent 10,918,617 would typically describe an invention in a specific technological field. For instance, if it falls under the category of electrical engineering or computer technology, it would be part of the broader trends seen in the USPTO's patent grants, where these fields have been increasingly prominent[4].

Technological Classification

The patent would be classified under the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields. This classification helps in understanding the technological area the patent belongs to and how it fits into the broader patent landscape[4].

Claims Analysis

Types of Claims

Patent claims are the heart of any patent application, as they define the scope of the invention. There are typically two types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Language and Scope

The language used in the claims is critical. Metrics such as independent claim length and independent claim count can provide insights into the patent scope. Generally, narrower claims are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Patent Eligibility

The 2024 USPTO guidance update on AI patents is particularly relevant here. It emphasizes the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must show that the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. This means the claim must impose meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Practical Application and Real-World Benefits

Integrating Abstract Ideas

To be patent-eligible, the claims must demonstrate how the abstract idea is applied in a practical manner. For example, if the patent involves AI, the claims should specify how the AI is used in a real-world application, such as enhancing the accuracy of voice commands in a hands-free environment[1].

Real-World Applications

Highlighting the real-world applications of the claimed method or system is essential. This could involve showing how the invention improves technology or provides a practical application that solves specific problems. For instance, if the patent is related to speech recognition, the claims should detail how the separated audio components are used to enhance accuracy in real-time systems[1].

Patent Landscape and Trends

USPTO Patent Activity

The USPTO awards a significant number of patents each year, with a notable increase in certain technological fields such as electrical engineering and computer technology. In 2018, for example, the USPTO granted 309,000 utility patents, with businesses receiving the majority of these patents[4].

Global and Comparative Trends

Patent trends are not isolated to the United States; they are part of a global system of invention, knowledge transfer, and innovation. The USPTO's activities reflect broader global trends, where there is a growing emphasis on intellectual property protection and innovation in various technological fields[4].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact the patent landscape by providing a more accessible and cost-effective way for smaller entities to enforce their patent rights. This initiative is part of broader legal and policy considerations aimed at fostering innovation and protecting intellectual property[2].

Recent Case Law and Guidance

The 2024 USPTO guidance update incorporates recent case law, which is crucial for understanding how patent eligibility is determined. This guidance helps practitioners draft claims that are more likely to avoid section 101 rejections, particularly in software-related patent applications[1].

Stakeholder Engagement and Public Input

Consultative Groups and Public Comments

The process of shaping patent policy and guidance often involves extensive stakeholder engagement. For instance, the study on a small claims patent court included public comments and input from a wide range of stakeholders, including academic experts and legal practitioners. This ensures that all perspectives are considered in the development of patent policies and procedures[2].

Key Takeaways

  • Patent Claims: The language and scope of patent claims are critical in defining the invention and determining patent eligibility.
  • Practical Application: Claims must demonstrate a practical application of the abstract idea to be patent-eligible.
  • Technological Trends: The patent fits into broader technological trends, with electrical engineering and computer technology being prominent areas.
  • Legal and Policy Considerations: Recent guidance updates and discussions on small claims patent courts are important for understanding the evolving patent landscape.
  • Stakeholder Engagement: Public input and stakeholder engagement play a significant role in shaping patent policies.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update refines and clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

How do claim metrics impact patent scope?

Metrics such as independent claim length and independent claim count can measure patent scope. Narrower claims are associated with a higher probability of grant and a shorter examination process than broader claims[3].

What is the role of a small claims patent court?

A small claims patent court aims to provide a more accessible and cost-effective way for smaller entities to enforce their patent rights, addressing issues of feasibility and structure through extensive stakeholder engagement and public input[2].

How are patents classified technologically?

Patents are classified under the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields. This helps in understanding the technological area the patent belongs to[4].

What are the implications of recent case law on patent eligibility?

Recent case law incorporated into the 2024 USPTO guidance update helps practitioners draft claims that are more likely to avoid section 101 rejections, particularly in software-related patent applications. It emphasizes the importance of integrating judicial exceptions into practical applications[1].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - NCSES NSF
  5. Report on Filing Patent/Trademark - United States Courts

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,918,617

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Banner Life Sciences BAFIERTAM monomethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 210296-001 Apr 28, 2020 RX Yes Yes 10,918,617 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.